Diabetes Mellitus and Risk of Hepatocellular Carcinoma

被引:39
|
作者
Li, Xu [1 ]
Wang, Xiaocong [2 ]
Gao, Pujun [1 ]
机构
[1] Jilin Univ, Hosp 1, Dept Hepatol, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China
[2] Jilin Univ, Hosp 1, Dept Echocardiog, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China
关键词
HEPATITIS-C VIRUS; FATTY LIVER-DISEASE; ACTIVATED RECEPTOR-GAMMA; CANCER-RISK; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; B-VIRUS; ALCOHOLIC LIVER; EPIDEMIOLOGIC EVIDENCE; ANTIDIABETIC THERAPY;
D O I
10.1155/2017/5202684
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The occurrence of hepatocellular carcinoma (HCC) is two to three times higher in patients with diabetes mellitus (DM), the prevalence of which is increasing sharply worldwide. The purpose of this review was to describe clinical links between DM and HCC and potential biological mechanisms that may account for this association. We evaluated the role of potential pathways that could account for the development of HCC with different etiologies in the presence of DM. In addition, we also briefly discuss the potential effect of other factors such as type and dosage of antidiabetic medicines and duration of DM on HCC risk.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma
    Polesel, J.
    Zucchetto, A.
    Montella, M.
    Dal Maso, L.
    Crispo, A.
    La Vecchia, C.
    Serraino, D.
    Franceschi, S.
    Talamini, R.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (02) : 353 - 357
  • [2] Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma?
    Gao, Chun
    Yao, Shu-Kun
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2009, 8 (05) : 465 - 473
  • [3] Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma
    Gao, Chun
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (27) : 1119 - 1127
  • [4] Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma
    Chun Gao
    [J]. World Journal of Hepatology, 2016, (27) : 1119 - 1127
  • [5] Diabetes mellitus: a “true” independent risk factor for hepatocellular carcinoma?
    Chun Gao and Shu-Kun YaoDepartment of Gastroenterology
    Graduate School
    [J]. Hepatobiliary & Pancreatic Diseases International, 2009, 8 (05) : 465 - 473
  • [6] Diabetes mellitus in patients with hepatocellular carcinoma
    Oshita, Masahide
    Ebara, Ryouichi
    Wada, Shigeo
    Aono, Satoshi
    Dairi, Higashi
    Ri, Tetsunari
    Yunokizaki, Hiroshi
    Koyama, Kumiko
    Fukutake, Nobuyasu
    Uda, Sou
    Kodama, Takahiro
    Mizutani, Masayo
    Okada, Akiyoshi
    Yasumaru, Masakazu
    Kawai, Naoki
    Abe, Takashi
    Tsujimoto, Masahiko
    Sato, Nobuhiro
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A166 - A166
  • [7] Diabetes mellitus and metformin in hepatocellular carcinoma
    Fujita, Koji
    Iwama, Hisakazu
    Miyoshi, Hisaaki
    Tani, Joji
    Oura, Kyoko
    Tadokoro, Tomoko
    Sakamoto, Teppei
    Nomura, Takako
    Morishita, Asahiro
    Yoneyama, Hirohito
    Masaki, Tsutomu
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (27) : 6100 - 6113
  • [8] Diabetes mellitus and metformin in hepatocellular carcinoma
    Koji Fujita
    Hisakazu Iwama
    Hisaaki Miyoshi
    Joji Tani
    Kyoko Oura
    Tomoko Tadokoro
    Teppei Sakamoto
    Takako Nomura
    Asahiro Morishita
    Hirohito Yoneyama
    Tsutomu Masaki
    [J]. World Journal of Gastroenterology, 2016, (27) : 6100 - 6113
  • [9] Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus
    Li, Qiaomei
    Xu, Hairong
    Sui, Chengjun
    Zhang, Hongjuan
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (02)
  • [10] INCREASED RISK OF HEPATOCELLULAR CARCINOMA AND THERAPY OF TYPE 2 DIABETES MELLITUS
    Perciaccante, A.
    Balbi, M.
    Casarin, P.
    Zanette, G.
    Donadon, V.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S296 - S296